In a double blind clinical trial for a drug neither the subjects nor the researcher knows who is in the conrol group or the experimantal group both the experimental and the control group subjects get the drug that is under trial neither the control group nor the experimental group receive the placebo both the groups get placebo and only the researchers are aware of this fact while both the groups are blinded of this fact both the experimental and control group subjects get placebo and the drug during any part of the study and are not aware of this double test

In a double blind clinical trial for a drug neither the subjects nor the researcher knows who is in the conrol group or the experimantal group both the experimental and the control group subjects get the drug that is under trial neither the control group nor the experimental group receive the placebo both the groups get placebo and only the researchers are aware of this fact while both the groups are blinded of this fact both the experimental and control group subjects get placebo and the drug during any part of the study and are not aware of this double test

Nutrition Now

8th Edition

ISBN:9781337415408

Author:Brown

Publisher:Brown

Chapter3: Ways Of Knowing About Nutrition

Section: Chapter Questions

Problem 17RQ

See similar textbooks

Similar questions

In regard to the difference margin (M), which of the following statements is NOT right? a. the difference margin should be chosen before the start of a trial b. the difference margin is a value randomly chosen by the researchers c. the difference margin is carefully chosen with both statistical and clinical considerations d. Non-inferiority and equivalence in efficacy between a new treatment and the standard treatment should be claimed in the presence of a well justified difference margin
Personal Learning: Here’s to the Future!I was surprised to find the literature so inconclusive about the benefits of therapeutic touch. Obviously, its adherents claim that they can measure its efficacy. Others find these claims unsupported. Since this event happened at the beginning of my clinical rotation, I decided to observeDanielle throughout my rotation. What I saw made me a believer in this technique. Danielle was using therapeutic touch as an adjuvant to other therapies and it seemed to be working. I want to learn more about this technique. My goal is to attend a workshop on therapeutic touch to see if it is something I can incorporate into my practice. Katherine Figliala, Georgetown University What does this tell you about yourself and about the adequacy of your competencies for professional practice?
Please give me a discussion/explanation of (INVITRO STUDIES AND INVIVO STUDIES) part in drug discovery and development.
You have an order for 1 gram of Cefazolin in D5W 100 ml. You have added 5 ml of sterile water to the 1 gram vial to reconstitute powder. However the recommended manufacturer’s diluent amount is 10 ml of sterile water for a final concentration of 100 mg/ml. How would reconstituting the vial with 5 mls affect the concentration and the final calculated dose. Please answer with explanation ASAP. I will really upvote. Thanks
Please give me a discussion/explanation of ( TARGET SELECTION ) part in drug discovery and development.
In a quantitative research journal found on the internet having a pharmacoepidemiologic study designs (such as quasi-experimental study design, quantitative research designs), give at least 5 positive and 5 negative points on the journal you have reviewed (please provide the title of the journal)
pls help me with the given question and explain. make sure its 100% correct A clinical trial was carried out to test whether a new treatment affects the recovery rate of patients suffering from a debilitating disease. The null hypothesis “H0: The treatment has no effect” was rejected with a P-value of 0.04. The researchers used a significance level of a = 0.05. State whether each of the following conclusions is correct. If not, explain why: a)The treatment has only a small effect () b)The treatment has some effect () c)The probability of committing a Type I error is 0.04 () d)The probability of committing a Type II error is 0.04 () e)The null hypothesis would not have been rejected had the significance level been set to a = 0.01 instead of 0.05. ()
Please give me a discussion/explanation of (LEAD DISCOVERY) part in drug discovery and development.
Drug A is being tested for its effectiveness in easing menopause symptoms. In designing an experiment to test Drug A, which of the following would be a valid approach? a. Participants can choose whether to be in the experimental or control group. b. The experimental group will contain only females and the control group will contain only males. c. Unlike the experimental group, the control group should include subjects whose age is above 52 years. d. The experimental group will receive Drug A and the control group will receive a placebo.
Please give me a discussion/explanation of (CLINICAL TRIAL) part in drug discovery and development.
A report from the U.S. National Academy of Sciencesand the National Academy of Medicine is recommendingthat germ-line therapy trials only be consideredfor serious conditions for which there is no reasonablealternative treatment option, and where both the risk–benefit options and broad oversight are available. Is thiskind of procedure ethical?
Briefly describe the steps involved in the development and approval of a new drug in the United States: List two pros and two cons about this process and what are your personal thoughts about it